News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 695 results

Carpmaels & Ransford promotes Jennifer Antcliff to partner

02-07-2020

European law firm Carpmaels & Ransford has promoted Jennifer Antcliff to partner in its dispute resolution team in its London office, bringing the total number of partners in the team to five.

English appeals court refuses Neurim injunction for insomnia drug

UK26-06-2020

The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 

Kymab victorious before UK Supreme Court in Regeneron appeal

UK24-06-2020Sarah Morgan

The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice. 

EC backs voluntary COVID-19 vaccine licensing

18-06-2020Rory O'Neill

The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

UKIPO rejects Novartis’s TM opposition attempt

UK18-06-2020Sarah Morgan

Switzerland-based Novartis has failed to convince the UK Intellectual Property Office that a trademark applied-for by Boston Healthcare should not be registered.

Roche and Innovent unite in $2bn biospecifics deal

China, Switzerland15-06-2020Sarah Morgan

Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.

Unitary SPC should follow new patent system: EC official

11-06-2020Rory O'Neill

The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Monster falls short in Merck TM dispute

UK09-06-2020Rory O'Neill

Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.

AG advises CJEU to uphold €94 million pay-for-delay fine

EU05-06-2020Sarah Morgan

The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme. 

English court gives Mylan green-light to sell generic insomnia drug

UK04-06-2020Sarah Morgan

In a victory for Mylan, the English High Court has rejected Israel-based pharmaceutical company Neurim’s attempt to delay a generic version of its insomnia medication.

Showing 1 to 10 of 695 results

LSIPR